Pancreatic Cancer Screening in a Population at High Risk
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMasaryk Memorial Cancer Institute
About this trial
Pancreatic cancer is one of the diseases with the worst prognosis, which is mainly due to the initial asymptomatic prognosis. Unfortunately, the incidence of this disease in the Czech Republic is still increasing. In a certain proportion of patients, it is possible to predict the disease, e.g. due to family burdens. Regular follow-up of such individuals is the subject of the SCREPAN study: "Pancreatic Cancer Screening in High-Risk Persons".
Eligibility criteria
Qualifiers
willing to participate in the study
age 18+
chronic pancreatic disease in the context of cystic fibrosis or chronic pancreatitis
age 50+
Disqualifiers
Inability to undergo radical curative surgery for a pancreatic tumor.
Inability to undergo scheduled imaging examinations.
Incurable malignant cancer.
Trial design
Treatments tested in this trial
- endoscopic ultrasonography
- magnetic resonance
- laboratory examination
Treatment groups
700 Participants
are divided into 4 treatment groupsSponsors and collaborators
Masaryk Memorial Cancer Institute
Lead sponsor
Masaryk University
Collaborator
Source ClinicalTrials.gov